Biosimilars

Your Professional Biosimilars Manufacturers

 

Suzhou Biosynergy Pharmaceutical Co., Ltd. was established in 2014, headquartered in Suzhou Industrial Park. It is a professional company engaged in the research and development, production, and sales of Biosimilars, APIs and intermediates. In the process of rapid development, the company has always followed the management philosophy of "integrity, professionalism, and innovation",

 
First 1234 Last
 
Why Choose Us

Our Factory

Biosynergy has an 84000 square meter biopharmaceutical research and production workshop in Changshu, Jiangsu, mainly producing monoclonal antibodies. Biosynergy has established research and development centers of over 1000 square meters in Nantong, Jiangsu and Jinan, Shandong, with a production site of 13500 square meters.

Various Products

Our advantageous products include monoclonal antibodies, ADC small molecule toxins, various fermented pharmaceutical raw materials and intermediates.

 

 

 

Production Market

Biosynergy has cooperated with many customers from India, Russia, Bangladesh, Vietnam, Pakistan, Türkiye, Saudi Arabia, Iran, Belarus, Egypt, etc.

 

Our Certificates

Under the strict management of IS09001 quality system, the company's products have passed a series of international standard certificates such as GMP, CE, FDA, ROHS, LFGB and so on.

 

Pharmacological action of Cetuximab Is An Antitumor Drug
 

Cetuximab is mainly effective by inhibiting cell proliferation, promoting cell apoptosis, and inhibiting blood vessel formation and metastasis:

 

By increasing the expression of cell cycle inhibitor p27kip, cells to stay in G1 phase, and cells decline in the S phase, thus inhibiting cell proliferation.

 

Induced tumor cell apoptosis by increasing Bax expression and decreasing bcl-2 expression, with bcl-2 being the apoptosis inhibitory gene and Bax being the apoptosis-promoting gene.

 

Reduce proangiogenic factors such as TGF- α, Chemicalbook bidirectional regulator, cripto and other tumor cell secreted growth factor and vascular endothelial growth factor VE GF, basal fibroblast growth factor bF GF, and interleukin-8 (IL-8) related to microvascular proliferation, inhibit tumor blood vessel formation and reduce the number of microvessels.

 

Cetuximab also inhibits tumor cell invasion and metastasis, which may be related to inhibiting the expression and activity of molecules (such as matrix metalloproteinase-9) that play a key role in tumor cell adhesion.

Cetuximab Is An Antitumor Drug

Usage and Dosage of Cetuximab Is An Antitumor Drug

 

Adalimumab Rheumatoid Arthritis Ankylosing Spondylitis

It is recommended that EGFR be tested in experienced laboratories according to the validated method; cetuximab alone must be administered under the guidance of a physician with experience with anticancer drugs. The condition of the patient must be closely monitored and must be equipped with resuscitation equipment. Before the first infusion of the product, the patient must receive antihistamine therapy, and Chemicalbook agreed before each subsequent use of the product. This product was administered once a week. The initial measurement is 400mg / m2 surface area, and then 250mg / m2 body surface area per week. For initial administration, the recommended infusion time is 120 minutes and 60 minutes for subsequent weekly administration, and the maximum infusion rate shall not exceed 5 ml/min.

 

Product Description of Cetuximab Is An Antitumor Drug

 

Product Name

Cetuximab

Synonyms

 

Morphological

Liquid

CAS

205923-56-4

Appearance

WHITE

Molecular Formula

C107H179N35O36S7

Molecular Weight

2756.23406

Assay

>99%

Application

For research purpose only

Storage

Store in a well-closed,light-resistant container

Remarks

NA

Custom synthesis

Available

 

Pharmacological properties of Bevacizumab Monoclonal Antibody

 

 

The estimated half life (a measure of drug action duration) of bevacizumab is approximately 20 days and the time taken for the drug to reach a steady-state concentration in the blood is around 100 days. The volume of distribution is 46 mL/kg and the drug is eliminated from the body at a rate of 2.75 to 5 mL/kg/day, depending on factors such as body weight, gender and extent or size of the tumor.

 

Apply of Bevacizumab Monoclonal Antibody

Used in the clinical treatment of tumors, such as in the treatment of psoriasis.

For the first-line treatment of patients with advanced colorectal cancer

For colon cancer and can also be used for breast cancer and lung Chemicalbook cancer. Overview, pharmacological effects, indications, adverse reactions, etc.

 

Product Specifications of Bevacizumab Monoclonal Antibody

 

Product Name

Bevacizumab monoclonal antibody

Class

Monoclonal

Type

Antibody

CAS number:

216974-75-3

Molecular formula:

C6638H10160N1720O2108S44

Einecs number:

200-160-3

Related:

Drug substance; mab 5; drug substance and intermediates; chemical reagent

Morphological :

Liquid

Color:

Colourless to light yellow

Condition of storage:

Store at -80°C

Solubility:

Dissolved in dimethyl sulfoxide

Shipping conditions

Ambient (domestic); Wet ice (international)

 

Packaging and Transportation

 

 

productcate-747-150

productcate-551-190

 

FAQ

Q: How long does it take to the goods arrived

A: It is Depending on your location:
5-7 days by DHL,UPS,TNT, FEDEX, HKEMS,Netherlands post.
7-20 days by DDP special line.
5-8 days by Air.
20-35 days by Sea.

Q: What's your MOQ ?

A: For the high value product, our MOQ starts from 1g and generally starts from 10gs. For other low, price product, our MOQ starts from 100g and 1kg.

Q: How to start orders or make payments ?

A: You can send our your Purchase order ( if your company has ), or just send a simple confirmation by email or by Trade Manager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.

Q: What payment methods does your company accept?

A: We accept various payment methods, including bank transfers, credit cards, and other secure online payment options. Our sales team will provide payment details upon order confirmation.

Q: How to confirm the Product Quality before placing orders?

A: We offer free sample,After you test the sample,you can know our quality.then place order.

As one of the leading biosimilars suppliers in China, we warmly welcome you to wholesale bulk biosimilars in stock here from our factory. Good service and quality products are available.

331731-18-1, The cholesterol drug Alirocumab, Daratumumab monoclonal antibody